ニュース - Pfizer

Monthly Subscription
for only
¥ 4,334
Trade Alert US
Monthly Subscription
for only
¥ 6,985
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
¥ 4,399
名称 銘柄コード 市場 種別
Pfizer Inc PFE NYSE 普通株式
  前日比 前日比 % 現在値 時刻
-0.54 -0.97% 55.00 09:58:34
始値 安値 高値 終値 前日終値
54.93 54.51 55.38 54.95 55.54
この銘柄の詳細情報 »


日付 時間 ソース タイトル
2022/1/1506:14SEEKPfizer granted FDA approval for CIBINQO in atopic dermatitis
2022/1/1505:30BWU.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults..
2022/1/1504:51EDGARStatement of Changes in Beneficial Ownership (4)
2022/1/1422:32SEEKCOVID-19 vaccine makers fall as top health officials..
2022/1/1404:15TRMNPfizer Stock: Discounted Valuation Multiples?
2022/1/1321:59TRMNPfizer Reveals Positive Results from Phase 3 Study of..
2022/1/1321:12SEEKPfizer in talks with Africa CDC to supply COVID-19 pill
2022/1/1317:52SEEKCalls grow to treat COVID like an 'endemic' illness
2022/1/1221:37DJNPfizer Reports Positive Results From Study Co-Administering..
2022/1/1221:01SEEKPfizer reports positive results from Phase 3 study of..
2022/1/1220:45BWPositive Top-Line Results of Pfizer’s Phase 3 Study..
2022/1/1202:15SEEKDren Bio in up to $1B deal with Pfizer for oncology..
2022/1/1123:10TRMNPfizer (PFE) Receives a Hold from Barclays
2022/1/1120:10SEEKU.S. COVID-19 hospitalizations surpass last winter record as..
2022/1/1107:44SEEKPfizer wins $442.13M Army contract modification for PAXLOVID
2022/1/1100:25SEEKPfizer CEO: Strategic mRNA investments will leverage..
2022/1/1023:16EDGARInitial Statement of Beneficial Ownership (3)
2022/1/1021:37DJNCodex DNA in Strategic, Licensing Deal With Pfizer
2022/1/1020:53SEEKPfizer in pact with Acuitas for LNP delivery system for use..
2022/1/1020:48DJNPfizer, Beam Therapeutics Form Multi-Target Research..
2022/1/1020:30BWPfizer Enters into Agreement with Acuitas Therapeutics for..
2022/1/1020:19SEEKBeam gains 8% on collaboration with Pfizer to advance in..
2022/1/1020:00GLOBEPfizer and Beam Enter Exclusive Multi-Target Research..
2022/1/0802:39DJNCanada Decision on Oral Covid-19 Drugs Likely Weeks Away
2022/1/0801:00TRMNPfizer (PFE) Gets a Hold Rating from Goldman Sachs
2022/1/0719:16SEEKWhat's at stake as the Supreme Court weighs vaccine..
2022/1/0707:32DJNJ&J: Study Shows 'Real World Evidence' of Covid Vaccine's..
2022/1/0620:32TRMNPfizer & BioNTech Ink Collaboration Deal to Develop..
2022/1/0523:35TRMNPfizer to Supply U.S. Government with 10M Additional Courses..
2022/1/0522:43SEEKPfizer upgraded to buy from neutral at BofA; sees 28% upside
2022/1/0521:37DJNPfizer, BioNTech to Collaborate on Shingles Vaccine
2022/1/0521:01SEEKPfizer, BioNTech in pact for mRNA-based shingles vaccine
2022/1/0521:00PRNUSBiohaven and Pfizer Complete Collaboration Transaction for..
2022/1/0520:45BWPfizer and BioNTech Sign New Global Collaboration Agreement..
2022/1/0504:17EDGARStatement of Changes in Beneficial Ownership (4)
2022/1/0504:17EDGARStatement of Changes in Beneficial Ownership (4)
2022/1/0504:17EDGARStatement of Changes in Beneficial Ownership (4)
2022/1/0502:50TRMNPfizer Lands Approval for New Non-COVID Drug
2022/1/0502:29DJNPfizer Gets U.S. Order for 10 Million More Covid-19 Pill..
2022/1/0502:00SEEKPfizer to deliver additional 10M courses of oral COVID-19..
2022/1/0501:45BWPfizer to Provide U.S. Government with an Additional 10..
2022/1/0501:33DJNPfizer on Track for Worst Two-Day Stretch Since June 2020 --..
2022/1/0501:02SEEKCDC backs use of a third Pfizer/BioNTech COVID-19 shot for..
2022/1/0500:00BWPfizer Invites Public to Listen to Webcast of Pfizer..
2022/1/0421:44TRMNTheranos CEO Elizabeth Holmes Found Guilty in a Lengthy..
2022/1/0417:42SEEKU.S. schools delay openings amid COVID-19 surge driven by..
2022/1/0417:00SEEKU.S. daily COVID-19 cases top 1 million as Omicron rages
2022/1/0400:28EDGARStatement of Changes in Beneficial Ownership (4)
2022/1/0400:28EDGARStatement of Changes in Beneficial Ownership (4)
2022/1/0323:58SEEKFDA expands Pfizer/BioNTech COVID booster shot to 12 to..
この銘柄に関するニュースをもっと見る »
今すぐ無料会員登録 し、ADVFNのストリーミングモニターで株価情報を見よう!

モニターには110もの銘柄を一度に表示することができ、またこれらは全て無料 でお使いいただけます。

ADVFNのサービスをご利用いただくには、 利用規約

P: V: D:20220116 09:41:45